Immunological Pathomechanisms of Spongiotic Dermatitis in Skin Lesions of Atopic Dermatitis

Int J Mol Sci. 2022 Jun 15;23(12):6682. doi: 10.3390/ijms23126682.

Abstract

Atopic dermatitis (AD) is a chronic pruritic skin disease with a complex pathogenesis underlying its heterogeneous clinical phenotypes and endotypes. The skin manifestation of AD reflects the cytokine milieu of a type-2-dominant immunity axis induced by genetic predisposition, innate immunity dysregulation, epidermal barrier defects, and allergic inflammation. However, the detailed pathomechanism of eczematous dermatitis, which is the principal characteristic of AD, remains unclear. This review examines previous studies demonstrating research progress in this area and considers the immunological pathomechanism of "spongiotic dermatitis", which is the histopathological hallmark of eczematous dermatitis. Studies in this field have revealed the importance of IgE-mediated delayed-type hypersensitivity, the Fas/Fas-ligand system, and cell-mediated cytotoxicity in inducing the apoptosis of keratinocytes in spongiotic dermatitis. Recent studies have demonstrated that, together with infiltrating CD4 T cells, IgE-expressing dendritic cells (i.e., inflammatory dendritic epidermal cells and Langerhans cells) that capture specific allergens (i.e., house dust mites) are present in the spongiotic epidermis of lichenified eczema in patients with IgE-allergic AD. These findings suggest that IgE-mediated delayed-type hypersensitivity plays a pivotal role in the pathogenesis of spongiotic dermatitis in the skin lesions of AD.

Keywords: Fas/Fas-ligand system; IgE-mediated delayed-type hypersensitivity; Langerhans cells; apoptosis; atopy patch test; cell-mediated cytotoxicity; eczematous dermatitis; inflammatory dendritic epidermal cells; lichenified eczema; spongiosis.

Publication types

  • Review

MeSH terms

  • Allergens
  • Chronic Disease
  • Dermatitis, Atopic*
  • Eczema* / complications
  • Humans
  • Hypersensitivity*
  • Immunoglobulin E

Substances

  • Allergens
  • Immunoglobulin E

Grants and funding

This research received no external funding.